![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61P 35/00 | |
A61K 39/395 | |||
A61K 45/06 | |||
A61K 31/519 | |||
A61P 37/00 |
(11) | Patento numeris | 2914343 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13792152.4 |
Europos patento paraiškos padavimo data | 2013-11-01 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-09-09 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2013/067956 |
Data | 2013-11-01 |
(87) | Numeris | WO 2014/071125 |
Data | 2014-05-08 |
(30) | Numeris | Data | Šalis |
CH45952012 | 2012-11-02 | IN | |
201361771812 P | 2013-03-02 | US |
(72) |
WEISS, Michael, US
MISKIN, Hari, US
SPORTELLI, Peter, US
VAKKALANKA, Swaroop K.V.S., CH
|
(73) |
Laboratoire Franēais du Fractionnement et des Biotechnologies,
3, Avenue des Tropiques ZA de Courtaboeuf, 91940 Les Ulis,
FR
Rhizen Pharmaceuticals S.A., Fritz Courvoisier 40, 2300 La Chaux de Fonds, CH TG Therapeutics, Inc., 2 Gansevoort St., 9th Floor, New York, NY 10014, US |
(54) | COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR |
COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR |